Gainers
- Venus Concept Inc. VERO jumped 54.9% to settle at $0.5419 on Friday. The company, last month, posted downbeat quarterly results.
- PaxMedica, Inc. PXMD climbed 47.7% to settle at $5.17 on Friday. PaxMedica Executive Chairman, Director Michael Derby reported in Form4 filing the purchase of 95,000 shares at $5.25 per share.
- Sunrise New Energy Co., Ltd. EPOW gained 31.5% to close at $2.80.
- Wheeler Real Estate Investment Trust, Inc. WHLR jumped 26.9% to close at $2.65.
- Rubius Therapeutics, Inc. RUBY gained 23.4% to close at $0.9254. The company, last month, posted a narrower-than-expected quarterly loss.
- Pear Therapeutics, Inc. PEAR jumped 21.7% to close at $2.13.
- Bright Minds Biosciences Inc. DRUG rose 21.4% to close at $1.93. Bright Minds Biosciences recently initiated dosing in Phase I clinical trial of BMB-101 for Dravet Syndrome.
- NewAge, Inc. NBEV shares jumped 21.3% to close at $0.1482 on Friday on continued volatility after the company recently announced it filed a voluntary petition for relief under chapter 11 of the United States Bankruptcy Code. The stock is rebounding after trading lower on Thursday.
- Liquidia Corporation LQDA gained 20.6% to close at $5.86. Needham maintained Liquidia with a Buy and raised the price target from $12 to $16.
- Reviva Pharmaceuticals Holdings, Inc. RVPH surged 18.8% to close at $2.66.
- Forza X1, Inc. FRZA jumped 18.1% to close at $4.39.
- United Maritime Corporation USEA rose 17.4% to close at $1.42 after the company announced a $3 million buyback plan.
- Hollysys Automation Technologies Ltd. HOLI jumped 16.5% to close at $19.76. A consortium led by China's Hollysys Automation’s management aims to take the U.S.-listed automation and control system maker private in a deal at a $1.8 billion valuation, Reuters reported.
- TScan Therapeutics, Inc. TCRX jumped 16.4% to close at $3.27. TScan Therapeutics, last month, posted a Q2 loss of $0.63 per share.
- Rain Therapeutics Inc. RAIN rose 15.8% to settle at $5.50.
- Aurora Innovation, Inc. AUR gained 15.2% to close at $2.43 after the company's CEO reportedly said an Apple or Microsoft takeover was 'potentially appealing'
- Werewolf Therapeutics, Inc. HOWL jumped 14% to close at $6.93 after the company on Thursday initiated patient dosing in its Phase 1/1b trial of WTX-124.
- DBV Technologies S.A. DBVT surged 12.9% to close at $2.18. DBV Technologies, last month, posted a Q2 loss of $0.35 per share.
- Borr Drilling Limited BORR rose 12.6% to close at $4.46. Shares of several companies in the energy sector traded higher as investors await an OPEC+ meeting next week, in which an oil output cut might be discussed.
- Smartsheet Inc. SMAR gained 10.8% to close at $34.16 after the company reported better-than-expected Q2 sales results.
- Cheetah Mobile Inc.. CMCM shares gained 10.5% to close at $3.70 following effectiveness of its 1-for-5 reverse split.
- nCino, Inc. NCNO climbed 9.5% to close at $32.16 after the company reported better-than-expected Q2 adjusted EPS and sales results and issued Q3 and FY23 adjusted EPS and sales guidance above estimates.
- Helmerich & Payne, Inc. HP rose 8.5% to close at $44.45. Shares of several companies in the energy sector traded higher as investors await an OPEC+ meeting next week, in which an oil output cut might be discussed. Also, G7 nations agreed on a plan to cap Russian oil prices.
- AMC Entertainment Holdings, Inc. APE gained 8.3% to close at $4.97.
- 5E Advanced Materials Inc. FEAM rose 8.1% to close at $15.99.
- HighPeak Energy, Inc. HPK gained 8% to close at $26.35.
- Ampio Pharmaceuticals, Inc. AMPE rose 7.7% to close at $0.0992 after declining around 9% on Thursday.
- AgriFORCE Growing Systems Ltd. AGRI gained 7.1% to close at $1.95. The company announced the upcoming launch of un(Think) Awakened Flour.
- Lululemon Athletica Inc. LULU jumped 6.7% to settle at $314.17 as the company reported better-than-expected results for its second quarter and boosted its annual projections.
- Okta, Inc. OKTA gained 6.7% to close at $64.63. Guggenheim upgraded Okta from Sell to Neutral.
Losers
- PolyPid Ltd. PYPD shares dipped 73.5% to close at $1.43 on Friday after the company announced its SHIELD I study did not achieve its primary endpoint of reduction in surgical site infections and mortality.
- Shuttle Pharmaceuticals Holdings, Inc. SHPH tumbled 71.6% to settle at $14.90 amid post-IPO volatility.
- Addentax Group Corp. ATXG fell 68% to close at $9.59. Addentax shares tumbled 95% on Thursday following the company's uplisting and IPO.
- ShiftPixy, Inc. PIXY dropped 33.9% to settle at $13.60. ShiftPixy recently announced a 1-for-100 reverse stock split.
- Hempacco Co., Inc. HPCO fell 32.5% to close at $5.64 on post-IPO volatility.
- Creatd, Inc. CRTD declined 31.1% to settle at $0.3758. Creatd received delist decision and received 15 days to file appeal.
- Virax Biolabs Group Limited VRAX fell 28.9% to close at $5.64 after jumping 59% on Thursday.
- Kuke Music Holding Limited KUKE fell 27.4% to close at $0.82. The company, last month, reported Q2 results.
- Amylyx Pharmaceuticals, Inc. AMLX declined 23.2% to close at $18.08 after a majority of FDA committee members voted the company's data for AMX0035 is not effective in the treatment of ALS patients.
- IN8bio, Inc. INAB fell 16.6% to close at $2.41. A Form 4 Filing recently showed Cavu Advisors purchased 51,214 shares at an average price of $2.02.
- TDH Holdings, Inc. PETZ fell 16.3% to close at $3.70.
- TDH Holdings recently announced it acquired all of the equity interest of Beijing Wenxin Company from Kargo Services.
- Calavo Growers, Inc. CVGW dipped 15.9% to close at $35.09 after reporting downbeat Q3 earnings.
- GigaCloud Technology Inc. GCT fell 15.3% to settle at $20.04.
- bioAffinity Technologies, Inc. BIAF dipped 15.1% to close at $7.05 after jumping 36% on Thursday. The company priced its IPO at $6.125 per unit.
- MDJM Ltd MDJH dropped 13.1% to close at $1.86.
- Reunion Neuroscience Inc. REUN declined 12.7% to close at $3.02.
- China SXT Pharmaceuticals, Inc. SXTC fell 11.1% to settle at $1.20.
- Vivani Medical, Inc. VANI declined 11.1% to close at $3.52.
- AMTD Digital Inc. HKD fell 10.9% to close at $100.01.
- Arcutis Biotherapeutics, Inc. ARQT declined 10.3% to close at $24.11. Arcutis Biotherapeutics recently completed the enrollment of subject in its INTEGUMENT-2 pivotal Phase 3 trial of roflumilast cream 0.15% in adults and children with Atopic dermatitis (AD).
- Vera Therapeutics, Inc. VERA declined 10.2% to close at $19.21. Vera Therapeutics, last month, posted a Q2 loss of $0.55 per share.
- Alpha Tau Medical Ltd. DRTS dropped 9.9% to close at $6.68. Alpha Tau Medical recently posted a Q2 loss of $0.03 per share.
- Pacific Biosciences of California, Inc. PACB fell 9.7% to close at $5.32.
- Ocugen, Inc. OCGN dropped 8.4% to close at $2.40.
- Peloton Interactive, Inc. PTON fell 8.2% to close at $9.44. UBS maintained Peloton Interactive with a Sell and lowered the price target from $13 to $8.
- Lands' End, Inc. LE fell 7.6% to settle at $10.81. Lands' End recently issued Q3 EPS and sales and FY22 EPS guidance below estimates.
- RiceBran Technologies RIBT fell 5.8% to close at $2.58.
- NIO Inc. NIO fell 5.6% to settle at $17.73. Shares of Chinese companies traded lower amid lockdown measures in Chengdu as COVID-19 cases in China rise.
- Array Technologies, Inc. ARRY fell 5.6% to close at $20.27.
- Meta Platforms, Inc. META dropped 3.1% to close at $160.32. Meta Platforms agreed to use Qualcomm produced custom chipsets for its Quest virtual reality devices at Berlin's consumer electronics conference, Reuters reported.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Posted In: NewsPenny StocksSmall CapPre-Market OutlookMarketsMoversTrading IdeasApparel, Accessories & Luxury GoodsConsumer DiscretionaryMovers From YesterdayTop Gainers
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in